528 related articles for article (PubMed ID: 19293145)
1. Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.
Buckingham SD; Jones AK; Brown LA; Sattelle DB
Pharmacol Rev; 2009 Mar; 61(1):39-61. PubMed ID: 19293145
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
[TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid peptide--nicotinic acetylcholine receptor interaction: the two faces of health and disease.
Dineley KT
Front Biosci; 2007 Sep; 12():5030-8. PubMed ID: 17569627
[TBL] [Abstract][Full Text] [Related]
4. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
Kar S; Slowikowski SP; Westaway D; Mount HT
J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
[TBL] [Abstract][Full Text] [Related]
5. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic acetylcholine receptor interaction with beta-amyloid: molecular, cellular, and physiological consequences.
Parri RH; Dineley TK
Curr Alzheimer Res; 2010 Feb; 7(1):27-39. PubMed ID: 20205670
[TBL] [Abstract][Full Text] [Related]
7. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
Hu M; Waring JF; Gopalakrishnan M; Li J
J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
Ren Z; Yang M; Guan Z; Yu W
Curr Alzheimer Res; 2019; 16(1):39-48. PubMed ID: 30345917
[TBL] [Abstract][Full Text] [Related]
9. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
Oz M; Lorke DE; Yang KH; Petroianu G
Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid, neuronal death and Alzheimer's disease.
Carter J; Lippa CF
Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
Farhat SM; Ahmed T
Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
[TBL] [Abstract][Full Text] [Related]
13. A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.
Liu Q; Xie X; Lukas RJ; St John PA; Wu J
J Neurosci; 2013 Apr; 33(17):7253-63. PubMed ID: 23616534
[TBL] [Abstract][Full Text] [Related]
14. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
15. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Green KN; Liang K; Tran L; Chen Y; Leslie FM; LaFerla FM
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3046-51. PubMed ID: 15705720
[TBL] [Abstract][Full Text] [Related]
16. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
Wang HY; Lee DH; D'Andrea MR; Peterson PA; Shank RP; Reitz AB
J Biol Chem; 2000 Feb; 275(8):5626-32. PubMed ID: 10681545
[TBL] [Abstract][Full Text] [Related]
17. Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain.
Wang HY; Stucky A; Liu J; Shen C; Trocme-Thibierge C; Morain P
J Neurosci; 2009 Sep; 29(35):10961-73. PubMed ID: 19726654
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neuronal nicotinic receptor by quinolizidine alkaloids causes neuroprotection on a cellular Alzheimer model.
Araya JA; Ramírez AE; Figueroa-Aroca D; Sotes GJ; Pérez C; Becerra J; Saez-Orellana F; Guzmán L; Aguayo LG; Fuentealba J
J Alzheimers Dis; 2014; 42(1):143-55. PubMed ID: 24825567
[TBL] [Abstract][Full Text] [Related]
20. beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
Pettit DL; Shao Z; Yakel JL
J Neurosci; 2001 Jan; 21(1):RC120. PubMed ID: 11150356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
